Paper8534872
The clinical experience with antiangiogenic agents.
Marshall JL and 1 other. Breast Cancer Res Treat, 1995. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. The clinical experience with antiangiogenic agents. Papers, record 8534872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8534872
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Neovascularization, Pathologic | Major topic |
| Clinical Trials as Topic | |
| Humans |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2710192 | Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. | N Engl J Med | 1989 | https://conductscience.org/library/papers/2710192 | PubMed |
| 2 | 8468719 | Suramin, an active drug for prostate cancer: interim observations in a phase I trial. | J Natl Cancer Inst | 1993 | https://conductscience.org/library/papers/8468719 | PubMed |
| 3 | 8270611 | Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B beta-hemolytic streptococcus. | J Cancer Res Clin Oncol | 1993 | https://conductscience.org/library/papers/8270611 | PubMed |
| 4 | 7509184 | Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b. | Br J Ophthalmol | 1993 | https://conductscience.org/library/papers/7509184 | PubMed |
| 5 | 1279186 | Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. | J Natl Cancer Inst | 1992 | https://conductscience.org/library/papers/1279186 | PubMed |
| 6 | 1991638 | Impaired sulphation of phenol by the colonic mucosa in quiescent and active ulcerative colitis. | Gut | 1991 | https://conductscience.org/library/papers/1991638 | PubMed |
| 7 | 1279332 | Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. | Lancet | 1992 | https://conductscience.org/library/papers/1279332 | PubMed |
| 8 | 1489383 | Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1489383 | PubMed |
| 9 | 3958767 | Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon. | J Clin Oncol | 1986 | https://conductscience.org/library/papers/3958767 | PubMed |
| 10 | 7513432 | Thalidomide is an inhibitor of angiogenesis. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7513432 | PubMed |
| 11 | 7505321 | The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. | J Pediatr Surg | 1993 | https://conductscience.org/library/papers/7505321 | PubMed |
| 12 | 1882952 | Interferon alpha 2a for treatment of age-related macular degeneration. | Am J Ophthalmol | 1991 | https://conductscience.org/library/papers/1882952 | PubMed |
| 13 | 7707422 | Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. | J Natl Cancer Inst | 1995 | https://conductscience.org/library/papers/7707422 | PubMed |
| 14 | 2570269 | Treatment of haemangioendotheliomas with alpha interferon. | Lancet | 1989 | https://conductscience.org/library/papers/2570269 | PubMed |
| 15 | 2926472 | Suramin: an anticancer drug with a unique mechanism of action. | J Clin Oncol | 1989 | https://conductscience.org/library/papers/2926472 | PubMed |
| 16 | 14296026 | CLINICAL EXPERIENCES WITH THALIDOMIDE IN PATIENTS WITH CANCER. | Clin Pharmacol Ther | 1965 | https://conductscience.org/library/papers/14296026 | PubMed |
| 17 | 1375283 | Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1375283 | PubMed |
| 18 | 2463087 | The sulfated polysaccharide-peptidoglycan complex potently inhibits embryonic angiogenesis and tumor growth in the presence of cortisone acetate. | Carbohydr Res | 1988 | https://conductscience.org/library/papers/2463087 | PubMed |
| 19 | 6192498 | Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. | Science | 1983 | https://conductscience.org/library/papers/6192498 | PubMed |
| 20 | 2161094 | Suramin-induced polyneuropathy. | Neurology | 1990 | https://conductscience.org/library/papers/2161094 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24477603 | An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks in Japanese patients with advanced solid tumors. | Cancer Chemother Pharmacol | 2014 | https://conductscience.org/library/papers/24477603 | PubMed |
| 9881776 | Structure-function relations of heparin-mimetic sulfated xylan oligosaccharides: inhibition of human immunodeficiency virus-1 infectivity in vitro. | Glycoconj J | 1998 | https://conductscience.org/library/papers/9881776 | PubMed |
| 9195284 | Development of angiogenesis inhibitors for cancer therapy. | Invest New Drugs | 1997 | https://conductscience.org/library/papers/9195284 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8534872
GET https://conductscience.org/api/papers/v1/8534872/references?page=2